President, BIO Ventures for Global Health
Jennifer has 20+ years of broad-based pharmaceutical and biotechnology experience, including negotiation and structuring of deals, and management of global discovery and commercial alliances. Jennifer began her career as a sales representative in Canada working in a variety of positions for Parke Davis/Pfizer and Genentech. Following the acquisition of Genentech Canada by Roche, Jennifer held a number of senior management positions in marketing, life cycle management, global product strategy, business development, and alliance management at Roche and Genentech in Canada, Switzerland, New Jersey, and South San Francisco. Jennifer co-founded Sound Biotechnology, and prior to that, served as Vice President, Business Development, Marketing, and Sales at CombiMatrix Corporation in Washington.
Jennifer graduated from the University of Western Ontario with a BSc, and she received her executive MBA at Western's Richard Ivey School of Business.
Cathyryne (Cathy) brings broad expertise in life sciences and grantmaking to BVGH, as well as over 12 years of experience in catalyzing and managing partnerships to promote research, advance product development, and improve health. Most recently, Cathy was a Senior Program Officer at the Life Sciences Discovery Fund, where she was responsible for grant program development, technology evaluation, award management, and communications. Previously, she was a Program Coordinator at SAIC (now Leidos), where she provided programmatic, scientific, and grant management support to the Congressionally Directed Medical Research Programs. Cathy received her Ph.D. in Biomedical Sciences (cancer and neuroinflammation research) from the University of California (UC), San Diego, and her B.S. in Biochemistry from UC Davis.
Katy obtained her bachelor's degree, Microbiology, honors, magna cum laude, from the University of Washington. She completed her Ph.D. in Virology at the University of Oxford, through the NIH Oxford Cambridge Scholars Program. Her graduate studies examined host-pathogen interactions of influenza viruses. Following her graduate work, she became a post-doctoral research fellow at the Rocky Mountain Laboratories in Montana, where she studied tick-borne flaviviruses. Katy taught an undergraduate microbiology course and mentored numerous laboratory students during her undergraduate and graduate studies.
Ujwal brings a strong background of scientific research knowledge and project management skills to BVGH. Her research interests, both as a post-doctoral researcher at Fred Hutchinson Cancer Research Center and as a graduate student, focused on understanding mechanisms of post transcriptional gene regulation at the mRNA level. Ujwal completed a certificate course in Biotechnology Project Management through the University of Washington/UCSD. Ujwal has a Master's degree in Microbiology from SIES College in Mumbai, India. She was a lecturer in Department of Microbiology at SIES College in Mumbai where she also organized and presented lectures and conducted labs. Ujwal received her Ph.D. in Molecular and Cellular Biology from University of Arizona.
Senior Program Manager
Amy obtained her bachelor’s degree, double majoring in Public Health and International Studies, from the University of Washington. Amy later went on to complete her Master of Public Health, as well as her Graduate Certificate in Health Informatics from the University of Michigan. Her graduate studies focused on health behavior, health education, and health communications. Prior to joining the team, she was an associate at a digital health company reviewing mobile health applications and devices through behavioral science and usability lenses.
Roopa graduated magna cum laude from Oregon State University with an Honors Bachelors of Science in Biology, minoring in Spanish and Chemistry. During her undergraduate career, Roopa completed a thesis focusing on Drosophila melanogaster genetics. In addition to experience in lab research, she has field experience volunteering abroad for public health programs targeting lower-income populations.
Mary graduated magna cum laude with a B.S. in Physiology and a Minor in Chemistry from Seattle Pacific University. While completing her degree at SPU Mary investigated germline development genes and embryonic protein composition in tardigrades. In 2014, Mary attended the Institute in Statistics and Modeling in Infectious Diseases at the University of Washington School of Public Health Department of Biostatistics. Later, she took the role as biostatistics lead on a study of intestinal cell fate in C. elegans at SPU. With a diverse background of work from outreach birthing clinics in the Philippines, to her years of employment in a small neighborhood clinic, Mary now bridges her clinical and academic backgrounds in the global health field.
Morgan brings a unique perspective to the field of global health. While beginning her academic career in science, she graduated from the University of Washington with a Bachelor of Arts in Political Science with a concentration in Comparative Government and Politics. Before joining BVGH, she received her Master of Science in Global Health and Public Policy from the University of Edinburgh. During her postgraduate study, Morgan facilitated a series of global health career development and networking workshops and completed an original research dissertation on the interaction between community initiatives and government policy for addressing the social determinants of health of marginalized populations.
Office Administrative Assistant
Erica brings a passion for engaging in efforts towards the creative renewal of human societies, participating in initiatives ranging from co-founding a grassroots community nonprofit to organizing around human rights issues. She has worked for over a decade in global and women’s health settings in various finance and administrative roles, including six years with PATH in Seattle. Her background, which also includes graduate studies in philosophy, cosmology and consciousness, produces a unique blend of vision and implementation. Erica enjoys connecting vision to results through a whole systems, collaborative approach, generating effective strategies, and responsive support and delivery systems. Erica completed her undergraduate studies in social justice and community organizing at Antioch University Seattle and received her MA from the California Institute of Integral Studies.
Dan Eramian, BA, MPA
Dan Eramian oversees communications and media strategy and execution at BVGH. He has over 20 years of experience in developing communication and investor programs in the biotechnology industry. Dan was the first Vice President of Communications for the Biotechnology Innovation Organization (BIO) in Washington DC. He worked closely with BVGH Board member and past BIO CEO and President, Carl Feldbaum to make BIO one of the most persuasive industry voices on Capitol Hill as well as promoting understanding and growth of the industry to the public and financial communities. Dan is a co-founder of Opus Biotech Communications, a communications firm aimed at emerging life sciences companies. Previously Dan was Senior Vice President of Communications and Investor Relations at three Seattle based biotechnology companies: KPI Therapeutics, Kineta, Inc. and Cell Therapeutics. Dan has served as Director of Public Affairs for the U.S. Department of Justice and the spokesman for the Attorney General of the United States. He was also Assistant Administrator for Public Affairs at the U.S. Small Business Administration which included its technology development programs. In addition Dan was Chief of Staff in the Massachusetts State Senate and was previously Executive Editor of Suburban World Newspapers also in Massachusetts. He holds a BA in English Literature UMass-Amherst and MPA from Suffolk University.